Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Covetrus, Inc.
  6. Summary
    CVET   US22304C1009

COVETRUS, INC.

(CVET)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/19/2021 10/20/2021 10/21/2021 10/22/2021 10/25/2021 Date
20.16(c) 20.3(c) 20.3(c) 20.19(c) 19.8(c) Last
738 876 449 122 388 948 412 915 560 733 Volume
+2.08% +0.69% 0.00% -0.54% -1.93% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 4 600 M - -
Net income 2021 -38,5 M - -
Net Debt 2021 750 M - -
P/E ratio 2021 -71,6x
Yield 2021 -
Sales 2022 4 902 M - -
Net income 2022 41,6 M - -
Net Debt 2022 661 M - -
P/E ratio 2022 65,3x
Yield 2022 -
Capitalization 2 725 M 2 725 M -
EV / Sales 2021 0,76x
EV / Sales 2022 0,69x
Nbr of Employees 5 466
Free-Float 75,1%
More Financials
Company
Covetrus, Inc., incorporated on April 13, 2018, is an animal-health technology and services company. The Company operates through three segments: North America, Europe, and Asia Pacific (APAC) & Emerging Markets. The Company's products and services include supply chain services, software services, and prescription management. The Supply Chain Services offers a portfolio of products and services and value-added... 
More about the company
Ratings of Covetrus, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about COVETRUS, INC.
09/27COVETRUS : Issues Inaugural Environmental, Social and Governance (ESG) Report
PU
09/09VC DAILY : Digital Health Is Booming, but VC Doesn't See a Bubble Forming
DJ
08/09COVETRUS : Barclays Adjusts Price Target on Covetrus to $38 From $46, Maintains Overweight..
MT
08/05COVETRUS : Q2 Earnings Snapshot
AQ
08/05COVETRUS : Management's Discussion and Analysis of Financial Condition and Results of Oper..
AQ
08/05Covetrus Seeks Acquisitions
CI
08/05COVETRUS : Earnings Flash (CVET) COVETRUS Reports Q2 Revenue $1.19B, vs. Street Est of $1...
MT
08/05COVETRUS, INC. : Results of Operations and Financial Condition, Financial Statements and E..
AQ
08/05COVETRUS : Announces Financial Results for Second Quarter of 2021
BU
08/05COVETRUS : Issues Inaugural Environmental, Social and Governance (ESG) Report
BU
08/05Covetrus Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six..
CI
08/03COVETRUS : Announces $120K in Scholarships to Support Diversity in Veterinary Sector
BU
07/29COVETRUS : Announces Second Quarter 2021 Earnings Release Date and Conference Call Informa..
BU
07/23COVETRUS : Drew Coxhead brings deep accounting experience to support Covetrus' transformat..
PU
07/23COVETRUS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
More news
News in other languages on COVETRUS, INC.
06/28COVETRUS : introduit de nouveaux postes et une nouvelle direction dans ses activités en Am..
06/28COVETRUS : besetzt neue Rollen und Führungspositionen in seinen nordamerikanischen und glo..
06/28COVETRUS : presenta nuevas funciones y cargos directivos en sus negocios de Norteamérica y..
03/08COVETRUS : anuncia al vicepresidente de la Gestión de Talentos a nivel Global
03/08COVETRUS : beruft Vice President of Global Talent Management
More news
Analyst Recommendations on COVETRUS, INC.
More recommendations
Stock Trading Strategies
COVETRUS, INC. - 2020
The stock is approaching a major resistance level
BUY
More Stock Trading Analysis
Chart COVETRUS, INC.
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 19,80 $
Average target price 30,60 $
Spread / Average Target 54,5%
EPS Revisions
Managers and Directors
Benjamin C. Wolin President, Chief Executive Officer & Director
Matthew J. Foulston Chief Financial Officer & Executive Vice President
Philip A. Laskaway Chairman
Georgina Wraight President-Global Technology Solutions & EVP
Steve Palmucci Global Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
COVETRUS, INC.-31.11%2 725
ABBOTT LABORATORIES15.61%224 403
MEDTRONIC PLC5.48%166 288
BECTON, DICKINSON AND COMPANY-1.52%70 767
HOYA CORPORATION20.25%55 682
DEXCOM, INC.53.72%54 986